Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022

SELL
$213.86 - $277.87 $201,456 - $261,753
-942 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$259.82 - $298.18 $64,955 - $74,545
-250 Reduced 20.97%
942 $248,000
Q4 2021

Feb 10, 2022

SELL
$271.6 - $314.21 $218,094 - $252,310
-803 Reduced 40.25%
1,192 $375,000
Q3 2021

Oct 13, 2021

BUY
$274.82 - $308.34 $18,138 - $20,350
66 Added 3.42%
1,995 $561,000
Q2 2021

Aug 10, 2021

BUY
$251.87 - $278.14 $182,605 - $201,651
725 Added 60.22%
1,929 $532,000
Q1 2021

May 11, 2021

BUY
$204.88 - $255.03 $20,488 - $25,503
100 Added 9.06%
1,204 $307,000
Q4 2020

Feb 08, 2021

SELL
$186.91 - $214.42 $4,859 - $5,574
-26 Reduced 2.3%
1,104 $225,000
Q3 2020

Nov 10, 2020

BUY
$167.03 - $201.3 $188,743 - $227,469
1,130 New
1,130 $213,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.3B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Portland Global Advisors LLC Portfolio

Follow Portland Global Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portland Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portland Global Advisors LLC with notifications on news.